Akili, Inc.
AKLI

$34.1 M
Marketcap
$0.43
Share price
Country
$0.00
Change (1 day)
$1.25
Year High
$0.19
Year Low

Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.

marketcap

P/B ratio for Akili, Inc. (AKLI)

P/B ratio as of 2023: 0.65

According to Akili, Inc.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.65. At the end of 2022 the company had a P/B ratio of 0.30.

P/B ratio history for Akili, Inc. from 2019 to 2023

P/B ratio at the end of each year

Year P/B ratio
2023 0.65
2022 0.30
2021 4.82
2020 -7.50
2019 -9.57